An electrical biosensor for the detection of circulating tumor cells.

In this report, we demonstrate a semi-integrated electrical biosensor for the detection of rare circulating tumor cells (CTCs) in blood. The sample was first enriched through a combination of immunomagnetic isolation and size filtration. The integration of both methods provided a high enrichment performance with a recovery rate above 70%, even for very low numbers of cancer cells present in the original sample (10 spiked MCF7 cells in 0.5 mL of blood). In the same system, the sample was then transferred to a microchip for further magnetic concentration, followed by immunochemical trapping and electronic detection by impedance spectroscopy. Three levels of spiked CTC number (30±2, 124±29, 273±23) in 10 μL of filtered blood sample were distinguished by monitoring the impedance change of the microelectrode array (MEA). The integration of different functions in a single system provided a methodology to process milliliter-sized blood samples at the macroscale and interface with the microdimensions of a highly sensitive electronic detector. The results showed that the whole system was able to detect different levels of spiked cancer cells without the use of time- and cost-intensive fluorescence labeling and image analysis. This has the potential to provide clinicians with a standalone system to monitor changes in CTC numbers throughout therapy conveniently and frequently for efficient cancer treatments.

[1]  Tanja Fehm,et al.  Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  Hong Wu,et al.  Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. , 2009, Angewandte Chemie.

[3]  Katharina Pachmann,et al.  Standardized quantification of circulating peripheral tumor cells from lung and breast cancer , 2005, Clinical chemistry and laboratory medicine.

[4]  Yanping Wang,et al.  Real-time monitoring approach: assessment of effects of antibodies on the adhesion of NCI-H460 cancer cells to the extracellular matrix. , 2008, Biosensors & bioelectronics.

[5]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[6]  William E Gillanders,et al.  Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  G. T. Budd,et al.  Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.

[8]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[9]  J. Wegener,et al.  Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. , 2000, Experimental cell research.

[10]  K. Sales,et al.  EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges , 2007, British Journal of Cancer.

[11]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[12]  R Handgretinger,et al.  Detection of circulating melanoma cells by immunomagnetic cell sorting , 1999, Journal of clinical laboratory analysis.

[13]  Michael L Pearl,et al.  Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. , 2009, Gynecologic oncology.

[14]  F. Becker,et al.  Isolation of rare cells from cell mixtures by dielectrophoresis , 2009, Electrophoresis.

[15]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[16]  Bernhard Gleich,et al.  Improved method for impedance measurements of mammalian cells. , 2009, Biosensors & bioelectronics.

[17]  Siyang Zheng,et al.  Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. , 2007, Journal of chromatography. A.

[18]  J. Reboud,et al.  Label-free impedance detection of low levels of circulating endothelial progenitor cells for point-of-care diagnosis. , 2010, Biosensors & bioelectronics.

[19]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.